The Classic Myeloproliferative Neoplasms

October 2011

Dr. Hanson is presenting the second in our series “Optimizing Laboratory Testing for Hematologic Disorders.” This series will address guidelines for appropriate laboratory test utilization in hematologic disorders and represents the combined effort of the Divisions of Hematopathology and Laboratory Genetics. This presentation will discuss the appropriate utilization of the JAK2 and MPL gene tests for evaluating possible myeloproliferative neoplasms.

Presenter:

• Curtis A. Hanson, MD of the Division of Hematopathology at Mayo Clinic in Rochester, Minnesota

Evaluation

• After viewing, complete the optional survey that appears.
• On the evaluation screen, submit any questions for the presenter. All questions and answers will be published on the Beyond Hot Topic page approximately one month after the Hot Topic posting.

Alternative Tests

• Hematopathology Consultation
• Chromosome Analysis, Hematologic Disorders, Bone Marrow
• BCR/ABL, mRNA Detection, Reverse Transcription PCR (RT_PCR) Qualitative, Diagnostic Assay
• BCR/ABL, Translocation 9;22, FISH (D-FISH)
• Erythropoietin (EPO), Serum
• JAK2 V617F Mutation Detection, Blood
• JAK2 V617F Mutation Detection, Bone Marrow
• JAK2 V617F Mutation Detection, Varies

Print Options

• Before viewing, print the Notes Pages.
• After viewing, obtain a Record of Viewing.

Hematologic Disorders Series

• Hot Topic: Leukocyte Alkaline Phosphatase Stain (LAP) - Optimizing Laboratory Testing for Hematologic Disorders Series
• Hot Topic: Classic Myeloproliferative Neoplasms

Forward to a Colleague

Share this presentation with:

• General Practitioners
• Hematologists
• Pathologists

If you have questions, e-mail .